Sauflon Pharmaceuticals Ltd in Eyewear (United Kingdom)

September 2015 | 2 pages | ID: S0D8CE150FEEN
Euromonitor International Ltd

Abstracts

Sauflon Pharmaceuticals is expected to continue to invest heavily in innovation in the forecast period, following its launch of the Sauflon Centre of Innovation in Hungary in December 2013. This will focus on developing higher-oxygen lenses, with an emphasis on improving consumers' experience and eye health. The company is also expected to continue to expand production capacity in the forecast period.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Contact Lenses, Spectacles.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Eyewear market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Sauflon Pharmaceuticals Ltd: Key Facts
Competitive Positioning
  Summary 2 Sauflon Pharmaceuticals Ltd: Competitive Position 2014